Market Place
Sourcing Support
All News #Library
Biotech
Sirnaomics Partners With Gore Range Capital For Aesthetic Medicine JV
31 Jul 2024 //
PR NEWSWIRE
Sirnaomics Completes IND-Enabling Studies For STP125G In Cardiovascular Care
11 Jul 2024 //
PR NEWSWIRE
Sirnaomics Completes STP707 Ph I Study With Strong Safety For Pancreatic Cancer
28 Jun 2024 //
PR NEWSWIRE
Sirnaomics Demonstrates Antitumor Activity Of Novel Conjugate
12 Jun 2024 //
PR NEWSWIRE
Sirnaomics Announces 2023 Annual Results
28 Mar 2024 //
PR NEWSWIRE
Sirnaomics will Present its Innovative Dual-Targeted GalNAc muRNA Programs
12 Mar 2024 //
PR NEWSWIRE
Sirnaomics to Present Latest Developments of STP705 for Focal Fat Reduction
05 Feb 2024 //
PR NEWSWIRE
Sirnaomics Publishes Novel Mechanism of Action of RNAi Cancer Therapeutic STP707
24 Jan 2024 //
PR NEWSWIRE
Sirnaomics Promotes Francois Lebel, M.D. to Chief Medical Officer
01 Dec 2023 //
PR NEWSWIRE
Sirnaomics Presents Positive Clinical Data of STP705 for Focal Fat Reduction
01 Nov 2023 //
PR NEWSWIRE
Sirnaomics Announces Successful Ph I Clinical Study of RNAi Therapeutic STP707
30 Aug 2023 //
PR NEWSWIRE
Sirnaomics Appoints Dr. Francois Lebel as Senior Vice President
27 Jul 2023 //
PR NEWSWIRE
Sirnaomics advances isSCC candidate into late-stage clinical development
20 Jun 2023 //
PHARMAFILE
Sirnaomics gears up for Phase III isSCC trial
20 Jun 2023 //
CLINICAL TRIALS ARENA
Sirnaomics Advances STP705 for SCC In Situ into Late-Stage Clinical DevP
19 Jun 2023 //
PR NEWSWIRE
Sirnaomics to Present Developments on GalAhead Therapeutic Platform
13 Jun 2023 //
PR NEWSWIRE
Sirnaomics Reports Interim Results of STP705 Phase I Clinical Study
05 Jun 2023 //
PR NEWSWIRE
Sirnaomics Dosed First Patient in PI Study of RNAi Therapeutic STP122G
01 Jun 2023 //
PR NEWSWIRE
Sirnaomics Announces 2022 Annual Results
28 Mar 2023 //
PR NEWSWIRE
Sirnaomics to Present Latest Developments in Polypeptide Nanoparticle Platform
20 Mar 2023 //
PR NEWSWIRE
Sirnaomics Accelerates Clinical Development of STP705
01 Feb 2023 //
PR NEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.